The Shaare Zedek Medical Center is a major hospital in Jerusalem established in 1902.

There are 1,000 beds in Shaare Zedek Medical Center.

During the past decade, Shaare Zedek Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shaare Zedek Medical Center" are "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Shaare Zedek Medical Center" in a lesser frequency.

Most popular intervention types in "Shaare Zedek Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (1 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials), "Placebo" (1 trials) and "Placebo SC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shaare Zedek Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Shaare Zedek Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Shaare Zedek Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shaare Zedek Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".